Trial Profile
Clinical Trials Insight: 700050453
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Jan 2014
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Sponsors Cypress Bioscience; Forest Laboratories
- 29 Oct 2009 New trial record.